Home/Filings/4/0000905148-24-003236
4//SEC Filing

Magrath George 4

Accession 0000905148-24-003236

CIK 0001228627other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 4:08 PM ET

Size

7.0 KB

Accession

0000905148-24-003236

Insider Transaction Report

Form 4
Period: 2024-11-15
Magrath George
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2024-11-15$1.01/sh+90,294$91,215483,244 total
  • Purchase

    Common Stock

    2024-11-18$1.02/sh+9,706$9,943492,950 total
Footnotes (2)
  • [F1]The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.975 to $1.05, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F2]The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.005 to $1.06, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Documents

1 file

Issuer

Opus Genetics, Inc.

CIK 0001228627

Entity typeother

Related Parties

1
  • filerCIK 0001999390

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 4:08 PM ET
Size
7.0 KB